Medicaid expansions and differences in guideline‐adherent cervical cancer screening between American Indian and White women
Cancer Medicine · 2023
DOI: 10.1002/cam4.5593 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Danielle R Gartner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: American Indian or Alaska Native, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.
Abstract (Originalsprache)
Background
Although preventable through screening, cervical cancer incidence and mortality are higher among American Indian and Alaska Native women (AIAN) than White women. The Patient Protection and Affordable Care Act's (ACA) Medicaid expansions may uniquely impact access and use of cervical cancer screening among AIAN women and ultimately alleviate this disparity.
Methods
Using Medicaid eligible AIAN ( N = 4681) and White ( N = 57,661) women aged 18–64 years from the 2010–2020 Behavioral Risk Factor Surveillance System, we implemented difference‐in‐differences regression to estimate the association between the Medicaid expansions and guideline‐adherent cervical cancer screening and health care coverage.
Results
The Medicaid expansions were not associated with guideline‐adherent cervical cancer screening (AIAN: −1 percentage point [ppt] [95% confidence interval, CI: −4, 2 ppts]; White: 3 ppts [95% CI: −0, 6 ppts]), but were associated with a 2 ppt increase (95% CI: 0, 4 ppt) in having had a pap test in the last 5 years among White women. The Medicaid expansions were also associated with increases in having a health plan (AIAN: 5 ppts [95% CI: 1, 9]; White: 11 ppts [95% CI: 7, 15]) and decreases in avoiding medical care due to costs (AIAN: −8 ppts [95% CI: −13, −2]; White: −6 ppts [95% CI: −9, −4]).
Conclusions
While we observed improvements in health care coverage, we did not observe changes to guideline‐adherent cervical cancer screening following the ACA's Medicaid expansions. Given the disproportionate burden of cervical cancer among AIAN women, identifying ways to improve cervical cancer screening uptake and delivery should be prioritized to reduce preventable deaths.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.
- Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Center for Immunization and Infection Research in Cancer, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Department of Oncologic Sciences, University of South Florida, Tampa, Florida, USA.
ORCID-Profile: Danielle R Gartner
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health
- Robert Wood Johnson Foundation
Zitieren
APA
Gartner, D. R., Islam, J. Y., & Margerison, C. E. (2023). Medicaid expansions and differences in guideline‐adherent cervical cancer screening between American Indian and White women. Cancer Medicine. https://doi.org/10.1002/cam4.5593
Vancouver
Gartner DR, Islam JY, Margerison CE. Medicaid expansions and differences in guideline‐adherent cervical cancer screening between American Indian and White women. Cancer Medicine. 2023. doi:10.1002/cam4.5593
BibTeX
@article{Gartner2023,
author = {Gartner, Danielle R and Islam, Jessica Y and Margerison, Claire E},
title = {Medicaid expansions and differences in guideline‐adherent cervical cancer screening between American Indian and White women},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5593}
}
EUVIMED